{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T19:49:49Z","timestamp":1791834589142,"version":"4.3.4"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"Netherlands Organisation for Health Research and Development","doi-asserted-by":"publisher","award":["10140022110037"],"award-info":[{"award-number":["10140022110037"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Reproductive Immunology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jri.2026.104949","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T15:40:55Z","timestamp":1786376455000},"page":"104949","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Oral corticosteroids in treatment of unexplained recurrent pregnancy loss; Rationale for administration in the PREMI trial"],"prefix":"10.1016","volume":"178","author":[{"given":"Lisa E.E.L.O.","family":"Lashley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Louise P.","family":"van der Hoorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jri.2026.104949_bib1","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0960-0760(93)90093-C","article-title":"Pathway and kinetics of prednisolone metabolism in the human placenta","volume":"44","author":"Addison","year":"1993","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"5","key":"10.1016\/j.jri.2026.104949_bib2","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.fertnstert.2023.08.949","article-title":"The role of uterine natural killer cells in recurrent pregnancy loss and possible treatment options","volume":"120","author":"B\u00e9quet","year":"2023","journal-title":"Fertil. Steril."},{"issue":"6","key":"10.1016\/j.jri.2026.104949_bib3","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-096545","article-title":"Effect of prednisolone on live birth rate in women with unexplained recurrent pregnancy loss: a study protocol for a double-blind, placebo-controlled, multicentre, randomised controlled trial (PREMI-study)","volume":"15","author":"B\u00e9quet","year":"2025","journal-title":"BMJ Open."},{"issue":"1","key":"10.1016\/j.jri.2026.104949_bib4","first-page":"hoad002","article-title":"ESHRE guideline: recurrent pregnancy loss: an update in 2022","volume":"2023","author":"Bender Atik","year":"2023","journal-title":"Hum. Reprod. Open."},{"issue":"8","key":"10.1016\/j.jri.2026.104949_bib5","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1093\/ckj\/sfab049","article-title":"Maternal, foetal and child consequences of immunosuppressive drugs during pregnancy in women with organ transplant: a review","volume":"14","author":"Boulay","year":"2021","journal-title":"Clin. Kidney J."},{"key":"10.1016\/j.jri.2026.104949_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jri.2018.10.001","article-title":"The effect of prednisolone on endometrial uterine NK cell concentrations and pregnancy outcome in women with reproductive failure. A retrospective cohort study","volume":"131","author":"Cooper","year":"2019","journal-title":"J. Reprod. Immunol."},{"issue":"1","key":"10.1016\/j.jri.2026.104949_bib7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00404-007-0527-x","article-title":"Treatment options and pregnancy outcome in women with idiopathic recurrent miscarriage: a randomized placebo-controlled study","volume":"278","author":"Fawzy","year":"2008","journal-title":"Arch. Gynecol. Obstet."},{"issue":"4","key":"10.1016\/j.jri.2026.104949_bib8","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1007\/s00404-023-07159-6","article-title":"Editorial expression of concern: treatment options and pregnancy outcome in women with idiopathic recurrent miscarriage: a randomized placebo-controlled study","volume":"308","author":"Fawzy","year":"2023","journal-title":"Arch. Gynecol. Obstet."},{"issue":"4","key":"10.1016\/j.jri.2026.104949_bib9","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00404-014-3262-0","article-title":"Combined oral prednisolone and heparin versus heparin: the effect on peripheral NK cells and clinical outcome in patients with unexplained recurrent miscarriage. A double-blind placebo randomized controlled trial","volume":"290","author":"Gomaa","year":"2014","journal-title":"Arch. Gynecol. Obstet."},{"issue":"3","key":"10.1016\/j.jri.2026.104949_bib10","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1046\/j.1365-2249.2003.02092.x","article-title":"Phenotypic characterization of human decidual macrophages","volume":"131","author":"Heikkinen","year":"2003","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.jri.2026.104949_bib11","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1210\/jc.2002-021174","article-title":"Steroid receptor expression in uterine natural killer cells","volume":"88","author":"Henderson","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.jri.2026.104949_bib12","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.jaci.2004.07.014","article-title":"Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma","volume":"114","author":"Karagiannidis","year":"2004","journal-title":"J. Allergy Clin. Immunol."},{"issue":"5","key":"10.1016\/j.jri.2026.104949_bib13","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/molehr\/gaaa019","article-title":"Prednisolone in early pregnancy inhibits regulatory T cell generation and alters fetal and placental development in mice","volume":"26","author":"Kieffer","year":"2020","journal-title":"Mol. Hum. Reprod."},{"issue":"10","key":"10.1016\/j.jri.2026.104949_bib14","doi-asserted-by":"crossref","first-page":"4027","DOI":"10.4049\/jimmunol.156.10.4027","article-title":"Endometrial T, B, and NK cells in patients with recurrent spontaneous abortion. Altered profile and pregnancy outcome","volume":"156","author":"Lachapelle","year":"1996","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.jri.2026.104949_bib15","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/humupd\/dmn021","article-title":"Potential significance of physiological and pharmacological glucocorticoids in early pregnancy","volume":"14","author":"Michael","year":"2008","journal-title":"Hum. Reprod. Update"},{"issue":"4","key":"10.1016\/j.jri.2026.104949_bib16","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1034\/j.1600-0897.2002.01048.x","article-title":"Distributions of endometrial NK cells, B cells, T cells, and Th2\/Tc2 cells fail to predict pregnancy outcome following recurrent abortion","volume":"47","author":"Michimata","year":"2002","journal-title":"Am. J. Reprod. Immunol."},{"issue":"2","key":"10.1016\/j.jri.2026.104949_bib17","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S0015-0282(99)00495-1","article-title":"Embryonic karyotype of abortuses in relation to the number of previous miscarriages","volume":"73","author":"Ogasawara","year":"2000","journal-title":"Fertil. Steril."},{"issue":"4","key":"10.1016\/j.jri.2026.104949_bib18","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.8755-8920.2000.440411.x","article-title":"Successful uterine steroid therapy in a case with a history of ten miscarriages","volume":"44","author":"Ogasawara","year":"2000","journal-title":"Am. J. Reprod. Immunol."},{"issue":"6","key":"10.1016\/j.jri.2026.104949_bib19","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1053\/beog.2001.0240","article-title":"Drugs in pregnancy. Rheumatological disorders","volume":"15","author":"Ostensen","year":"2001","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"issue":"6","key":"10.1016\/j.jri.2026.104949_bib20","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1210\/jc.2002-021710","article-title":"Mechanism of cortisol\/progesterone antagonism in the regulation of 15-hydroxyprostaglandin dehydrogenase activity and messenger ribonucleic acid levels in human chorion and placental trophoblast cells at term","volume":"88","author":"Patel","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"12","key":"10.1016\/j.jri.2026.104949_bib21","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1136\/jcp.46.12.1089","article-title":"Effects of single dose compared with three days' prednisolone treatment of healthy volunteers: contrasting effects on circulating lymphocyte subsets","volume":"46","author":"Pountain","year":"1993","journal-title":"J. Clin. Pathol."},{"issue":"12","key":"10.1016\/j.jri.2026.104949_bib22","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1093\/humrep\/deg502","article-title":"Successful pregnancy outcome following 19 consecutive miscarriages: case report","volume":"18","author":"Quenby","year":"2003","journal-title":"Hum. Reprod."},{"issue":"4","key":"10.1016\/j.jri.2026.104949_bib23","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.fertnstert.2005.05.012","article-title":"Prednisolone reduces preconceptual endometrial natural killer cells in women with recurrent miscarriage","volume":"84","author":"Quenby","year":"2005","journal-title":"Fertil. Steril."},{"issue":"1","key":"10.1016\/j.jri.2026.104949_bib24","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/humrep\/den348","article-title":"Uterine natural killer cells and angiogenesis in recurrent reproductive failure","volume":"24","author":"Quenby","year":"2009","journal-title":"Hum. Reprod."},{"issue":"9535","key":"10.1016\/j.jri.2026.104949_bib25","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0140-6736(06)69204-0","article-title":"Recurrent miscarriage","volume":"368","author":"Rai","year":"2006","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.jri.2026.104949_bib26","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1111\/1471-0528.17515","article-title":"Recurrent miscarriage green-top Guideline No. 17","volume":"130","author":"Regan","year":"2023","journal-title":"Bjog"},{"issue":"10","key":"10.1016\/j.jri.2026.104949_bib27","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1093\/humrep\/dew186","article-title":"Corticosteroid therapy in assisted reproduction - immune suppression is a faulty premise","volume":"31","author":"Robertson","year":"2016","journal-title":"Hum. Reprod."},{"issue":"1","key":"10.1016\/j.jri.2026.104949_bib28","article-title":"ESHRE guideline: recurrent pregnancy loss: an update in 2022\u2020","volume":"2023","author":"RPL","year":"2023","journal-title":"Human. Reprod. Open."},{"issue":"10378","key":"10.1016\/j.jri.2026.104949_bib29","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/S0140-6736(22)02610-1","article-title":"Cell-free fetal DNA for genetic evaluation in Copenhagen Pregnancy Loss Study (COPL): a prospective cohort study","volume":"401","author":"Schlaikj\u00e6r Hartwig","year":"2023","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.jri.2026.104949_bib30","doi-asserted-by":"crossref","first-page":"4988","DOI":"10.1210\/jc.2006-1472","article-title":"Induction of surfactant protein A expression by cortisol facilitates prostaglandin synthesis in human chorionic trophoblasts","volume":"91","author":"Sun","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"17","key":"10.1016\/j.jri.2026.104949_bib31","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1001\/jama.2023.5302","article-title":"Prednisone vs placebo and live birth in patients with recurrent implantation failure undergoing in vitro fertilization: a randomized clinical trial","volume":"329","author":"Sun","year":"2023","journal-title":"Jama"},{"issue":"7","key":"10.1016\/j.jri.2026.104949_bib32","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1093\/humrep\/det117","article-title":"A feasibility trial of screening women with idiopathic recurrent miscarriage for high uterine natural killer cell density and randomizing to prednisolone or placebo when pregnant","volume":"28","author":"Tang","year":"2013","journal-title":"Hum. Reprod."},{"issue":"2","key":"10.1016\/j.jri.2026.104949_bib33","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/humrep\/det398","article-title":"Menstrual blood closely resembles the uterine immune micro-environment and is clearly distinct from peripheral blood","volume":"29","author":"van der Molen","year":"2014","journal-title":"Hum. Reprod."}],"container-title":["Journal of Reproductive Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016503782600118X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016503782600118X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T19:27:52Z","timestamp":1791833272000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016503782600118X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":33,"alternative-id":["S016503782600118X"],"URL":"https:\/\/doi.org\/10.1016\/j.jri.2026.104949","relation":{},"ISSN":["0165-0378"],"issn-type":[{"value":"0165-0378","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral corticosteroids in treatment of unexplained recurrent pregnancy loss; Rationale for administration in the PREMI trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Reproductive Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jri.2026.104949","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104949"}}